Pages that link to "Q56786021"

The following pages link to Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck (Q56786021):

Displaying 19 items.

• Nucleic acid targeting: towards personalized therapy for head and neck cancer. (Q26850237) (← links)
• A snapshot of gene therapy in Latin America (Q26998837) (← links)
• Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8 memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection (Q30578697) (← links)
• Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis. (Q33900309) (← links)
• Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art (Q33907628) (← links)
• Strategies for cancer vaccine development (Q34038338) (← links)
• Therapeutic DNA vaccine reduces schistosoma mansoni-induced tissue damage through cytokine balance and decreased migration of myofibroblasts (Q35070198) (← links)
• New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro. (Q36013722) (← links)
• State of the art in tumor antigen and biomarker discovery. (Q37132800) (← links)
• Recent advances in DNA vaccines for autoimmune diseases (Q37386307) (← links)
• The current state of head and neck cancer gene therapy (Q37595513) (← links)
• Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies (Q37700356) (← links)
• The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy (Q37825430) (← links)
• Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients (Q40004825) (← links)
• Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients (Q40383030) (← links)
• HSP60: Issues and Insights on Its Therapeutic Use as an Immunoregulatory Agent (Q42102746) (← links)
• Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model. (Q43501419) (← links)
• Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery. (Q45057675) (← links)
• Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis (Q84359186) (← links)